ABSTRACT
OBJECTIVE: To estimate the numbers of COVID-19-related hospitalisations in Australia after re-opening the international border. DESIGN: Population-level deterministic compartmental epidemic modelling of eight scenarios applying various assumptions regarding SARS-CoV-2 transmissibility (baseline R0 = 3.5 or 7.0), vaccine rollout speed (slow or fast), and scale of border re-opening (mean of 2500 or 13 000 overseas arrivals per day). SETTING: Simulation population size, age structure, and age-based contact rates based on recent estimates for the Australian population. We assumed that 80% vaccination coverage of people aged 16 years or more was reached in mid-October 2021 (fast rollout) or early January 2022 (slow rollout). MAIN OUTCOME MEASURES: Numbers of people admitted to hospital with COVID-19, December 2021 - December 2022. RESULTS: In scenarios assuming a highly transmissible SARS-CoV-2 variant (R0 = 7.0), opening the international border on either scale was followed by surges in both infections and hospitalisations that would require public health measures beyond mask wearing and social distancing to avoid overwhelming the health system. Reducing the number of hospitalisations to manageable levels required several cycles of additional social and mobility restrictions. CONCLUSIONS: If highly transmissible SARS-CoV-2 variants are circulating locally or overseas, large and disruptive COVID-19 outbreaks will still be possible in Australia after 80% of people aged 16 years or more have been vaccinated. Continuing public health measures to restrict the spread of disease are likely to be necessary throughout 2022.
Subject(s)
COVID-19/epidemiology , Communicable Disease Control/statistics & numerical data , Communicable Diseases, Imported/epidemiology , Disease Outbreaks , Hospitalization/statistics & numerical data , Adolescent , Adult , Aged , Australia/epidemiology , COVID-19/prevention & control , COVID-19/virology , Communicable Disease Control/methods , Communicable Diseases, Imported/virology , Computer Simulation , Female , Humans , Male , Middle Aged , SARS-CoV-2 , Vaccination Coverage/statistics & numerical data , Young AdultABSTRACT
We report an imported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 detected in an asymptomatic traveler who arrived in Italy on an indirect flight from Brazil. This case shows the risk for introduction of SARS-CoV-2 variants from indirect flights and the need for continued SARS-CoV-2 surveillance.
Subject(s)
COVID-19 , Communicable Diseases, Imported , Diagnostic Screening Programs , SARS-CoV-2 , Spike Glycoprotein, Coronavirus/genetics , Adult , Brazil/epidemiology , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/immunology , COVID-19/virology , COVID-19 Serological Testing/methods , Carrier State/diagnosis , Carrier State/epidemiology , Communicable Diseases, Imported/diagnosis , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , Diagnostic Screening Programs/organization & administration , Diagnostic Screening Programs/standards , Humans , Italy/epidemiology , Male , Mutation , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Travel/statistics & numerical data , Travel-Related IllnessABSTRACT
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with higher transmission potential have been emerging globally, including SARS-CoV-2 variants from the United Kingdom and South Africa. We report 4 travelers from Brazil to Japan in January 2021 infected with a novel SARS-CoV-2 variant with an additional set of mutations.
Subject(s)
COVID-19 Drug Treatment , Communicable Diseases, Imported , SARS-CoV-2 , Adult , Basic Reproduction Number , Brazil/epidemiology , COVID-19/epidemiology , COVID-19/therapy , COVID-19/transmission , COVID-19/virology , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/physiopathology , Communicable Diseases, Imported/therapy , Communicable Diseases, Imported/virology , Hospitalization , Humans , Japan/epidemiology , Male , Mutation , Quarantine/methods , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Symptom Assessment/methods , Travel-Related Illness , Treatment OutcomeABSTRACT
The appearance of new variants of SARS-CoV-2 has recently challenged public health authorities with respect to tracking transmission and mitigating the impact in the evolving pandemic across countries. B.1.525 is considered a variant under investigation since it carries specific genetic signatures present in P.1, B.1.1.7, and B.1.351. Here we report genomic evidence of the first likely imported case of the SARS-CoV-2 B.1.525 variant, isolated in a traveler returning from Nigeria.
Subject(s)
COVID-19/virology , Communicable Diseases, Imported/virology , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Aged , Brazil/epidemiology , COVID-19/diagnosis , COVID-19/epidemiology , Communicable Diseases, Imported/diagnosis , Communicable Diseases, Imported/epidemiology , Female , Genome, Viral/genetics , Humans , Mutation , Nigeria/epidemiology , Travel-Related IllnessABSTRACT
After returning from Europe to the United States, on March 1, 2020, a symptomatic teacher received positive test results for severe acute respiratory syndrome coronavirus 2. Of the 21 students exposed to the teacher in the classroom, serologic results suggested past infection for 2. Classroom contact may result in virus transmission.
Subject(s)
Antibodies, Viral/blood , Betacoronavirus/immunology , Communicable Diseases, Imported/diagnosis , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Adolescent , Adult , Antibody Formation , COVID-19 , Child , Child, Preschool , Communicable Diseases, Imported/transmission , Communicable Diseases, Imported/virology , Coronavirus Infections/transmission , Coronavirus Infections/virology , Disease Transmission, Infectious , Female , Humans , Male , Pandemics , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2 , School Teachers , Schools , Students , Travel , United States/epidemiologyABSTRACT
An asymptomatic person infected with severe acute respiratory syndrome coronavirus 2 returned to Heilongjiang Province, China, after international travel. The traveler's neighbor became infected and generated a cluster of >71 cases, including cases in 2 hospitals. Genome sequences of the virus were distinct from viral genomes previously circulating in China.
Subject(s)
Betacoronavirus , Communicable Diseases, Imported/epidemiology , Coronavirus Infections/epidemiology , Disease Outbreaks , Pneumonia, Viral/epidemiology , Adult , Aged , Asymptomatic Infections/epidemiology , COVID-19 , China/epidemiology , Communicable Diseases, Imported/transmission , Communicable Diseases, Imported/virology , Coronavirus Infections/transmission , Female , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/transmission , SARS-CoV-2 , TravelABSTRACT
BACKGROUND: To better understand transmission dynamics, we characterized Plasmodium falciparum genetic diversity in Eswatini, where transmission is low and sustained by importation. METHODS: Twenty-six P. falciparum microsatellites were genotyped in 66% of confirmed cases (2014-2016; N = 582). Population and within-host diversity were used to characterize differences between imported and locally acquired infections. Logistic regression was used to assess the added value of diversity metrics to classify imported and local infections beyond epidemiology data alone. RESULTS: Parasite population in Eswatini was highly diverse (expected heterozygosity [HE] = 0.75) and complex: 67% polyclonal infections, mean multiplicity of infection (MOI) 2.2, and mean within-host infection fixation index (FWS) 0.84. Imported cases had comparable diversity to local cases but exhibited higher MOI (2.4 vs 2.0; P = .004) and lower mean FWS (0.82 vs 0.85; P = .03). Addition of MOI and FWS to multivariate analyses did not increase discrimination between imported and local infections. CONCLUSIONS: In contrast to the common perception that P. falciparum diversity declines with decreasing transmission intensity, Eswatini isolates exhibited high parasite diversity consistent with high rates of malaria importation and limited local transmission. Estimates of malaria transmission intensity from genetic data need to consider the effect of importation, especially as countries near elimination.
Subject(s)
Communicable Diseases, Imported/virology , DNA, Protozoan/genetics , Genome, Protozoan/genetics , Malaria, Falciparum/virology , Plasmodium falciparum/genetics , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/transmission , DNA, Protozoan/isolation & purification , Epidemiological Monitoring , Eswatini/epidemiology , Genetic Variation , Humans , Incidence , Malaria, Falciparum/epidemiology , Malaria, Falciparum/transmission , Microsatellite Repeats , Plasmodium falciparum/isolation & purification , Plasmodium falciparum/pathogenicityABSTRACT
There are various diagnostic and research methods for detecting cases of Dengue fever, the effectiveness of which is given in this work. MATERIALS AND METHODS: On biomaterial from 70 people, verification of imported cases of Dengue fever into the south of the Far East from 2012 to 2019 is shown. Serological and virological methods were used, as well as PCR. RESULTS: Using the immunochromatographic rapid test, the Dengue virus (DENV) NS1 antigen and antibodies to DENV (IgM and IgG) were detected in human blood. We examined 12 patients from the infectious diseases department with unknown fever and the blood of 58 people who applied to clinics in Vladivostok after returning from tourist trips. Dengue fever was diagnosed in 23 patients (32.8%), of which antigen was detected in 56%, IgM antibodies in 91.3% and IgG in 52.1%. In 2 cases (8.7%), only antigen was detected in patients. Three strains of the pathogen were isolated by virological methods from 18 blood samples, two of which turned out to be the DENV of the 1st genotype and one - of the DENV of the 2nd genotype. Using RT-PCR, 38 blood samples were tested positive in the immunochromatographic rapid test, of which in 16 cases (42.1%) a DENV marker was detected, in 11 cases it was genotype 1, in three cases genotype 2, and one each - genotypes 3 and 4. CONCLUSIONS: 1. The most reliable method of rapid verification (in 100%) the primary infection DENV was the comprehensive determination of antigen and antibodies of the IgM class; 2. With antigenemia, blood should be used to isolate the virus, as well as to diagnose the disease by PCR and to establish the genotype of the DENV; 3. When using only PCR to indicate Dengue virus, a significant proportion of the disease cases will not be diagnosed.
Subject(s)
Communicable Diseases, Imported/diagnosis , Dengue/diagnosis , Antibodies, Viral/isolation & purification , Antigens, Viral/isolation & purification , Communicable Diseases, Imported/virology , Dengue Virus , Genotype , Humans , Russia/epidemiologyABSTRACT
We report a disease outbreak caused by chikungunya virus in Zhejiang Province, China, in August 2017. Phylogenic analysis indicated that this virus belonged to the Indian Ocean clade of the East/Central/South African genotype and was imported by a traveler returning from Bangladesh.
Subject(s)
Chikungunya Fever/epidemiology , Chikungunya Fever/virology , Chikungunya virus , Disease Outbreaks , Bangladesh , Chikungunya Fever/history , Chikungunya virus/classification , Chikungunya virus/genetics , China/epidemiology , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , Genome, Viral , History, 21st Century , Humans , Phylogeny , Travel-Related IllnessABSTRACT
We report a case of monkeypox in a man who returned from Nigeria to Israel in 2018. Virus was detected in pustule swabs by transmission electron microscopy and PCR and confirmed by immunofluorescence assay, tissue culture, and ELISA. The West Africa monkeypox outbreak calls for increased awareness by public health authorities worldwide.
Subject(s)
Communicable Diseases, Imported/diagnosis , Communicable Diseases, Imported/epidemiology , Disease Outbreaks , Monkeypox virus , Mpox (monkeypox)/diagnosis , Mpox (monkeypox)/epidemiology , Animals , Biopsy , Chlorocebus aethiops , Communicable Diseases, Imported/history , Communicable Diseases, Imported/virology , History, 21st Century , Humans , Israel/epidemiology , Mpox (monkeypox)/history , Mpox (monkeypox)/virology , Skin/pathology , Skin/virology , Vero CellsABSTRACT
We tested samples of pork products confiscated from travelers to South Korea for African swine fever virus (ASFV). We detected ASFV in 4 food items confiscated from travelers from Shenyang, China, in August 2018. Surveillance of pork products at country entry points is needed to mitigate the risk for ASFV introduction.
Subject(s)
African Swine Fever Virus , African Swine Fever/epidemiology , African Swine Fever/virology , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , African Swine Fever/history , African Swine Fever/transmission , African Swine Fever Virus/classification , African Swine Fever Virus/genetics , African Swine Fever Virus/isolation & purification , Animals , China/epidemiology , Communicable Diseases, Imported/history , Communicable Diseases, Imported/transmission , Disease Outbreaks , Food Microbiology , Genome, Viral , History, 21st Century , Phylogeny , Pork Meat/virology , Red Meat/virology , Republic of Korea/epidemiology , SwineABSTRACT
Zika virus RNA has been detected in semen samples collected <370 days after symptom onset. We report unusual persistence of Zika virus RNA in semen, confirmed by sequencing at 515 days after symptom onset and detectable for >900 days, in a patient with immunosuppression.
Subject(s)
Immunocompromised Host , Semen/virology , Zika Virus Infection/epidemiology , Zika Virus Infection/virology , Zika Virus/classification , Zika Virus/genetics , Antirheumatic Agents/adverse effects , Antirheumatic Agents/therapeutic use , Biopsy , Communicable Diseases, Imported/diagnosis , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/transmission , Communicable Diseases, Imported/virology , Female , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Male , RNA, Viral , Rheumatic Diseases/complications , Rheumatic Diseases/diagnosis , Rheumatic Diseases/drug therapy , Travel-Related Illness , Viral Load , Zika Virus Infection/diagnosis , Zika Virus Infection/transmissionABSTRACT
AIMS: Little data have been published so far on the epidemiological aspects of hepatitis D virus (HDV) infection in immigrant populations and even poorer is the information on the virological, phylogenetic, and clinical aspects of this infection in these populations. This review article, aimed primarily at physicians caring for immigrants, summarizes the information available on HDV infection and analyzes data on this topic concerning the immigrant populations. METHODS AND RESULTS: The prevalence of HDV infection in HBsAg-positive immigrants varies according to the country of origin. For example, in immigrants from sub-Saharan Africa, this prevalence is higher in those born in Equatorial Guinea (24.4%) than those from other African countries (10.3%). The epidemiological impact of HDV infection linked to migratory flows is a function of the different endemicity between countries of origin and countries in which a new existence has been established. This impact is high when immigrants from areas endemic to HDV infection (eg, Equatorial Guinea) settle in areas of low endemicity (eg, Germany or England, with a prevalence of around 4%), while the impact is lesser or nonexistent if the migratory flows are directed toward countries with intermediate endemicity (eg, Italy and Greece, with a prevalence of around 10%). CONCLUSION: This impact of immigration on HDV epidemiology can be strong when HDV endemicity is high in the country of origin and low in the host country and slight when immigrants move to high or medium endemic countries.
Subject(s)
Communicable Diseases, Imported/epidemiology , Emigrants and Immigrants/statistics & numerical data , Hepatitis D/diagnosis , Africa/epidemiology , Antiviral Agents/therapeutic use , Coinfection/epidemiology , Coinfection/virology , Communicable Diseases, Imported/virology , Equatorial Guinea/epidemiology , Europe , Hepatitis D/drug therapy , Hepatitis D/epidemiology , Hepatitis Delta Virus/classification , Hepatitis Delta Virus/drug effects , Hepatitis Delta Virus/genetics , Humans , Phylogeny , PrevalenceABSTRACT
BACKGROUND: Chikungunya virus (CHIKV) is a widespread mosquito-borne virus representing a serious challenge to public health. The largest outbreak in the Middle-East was recorded in 2016-2017 in Pakistan. Sistan and Baluchistan Province of Iran shares a wide border with Pakistan; accordingly, introduction of CHIKV from Pakistan to Iran seems to be probable. The current study is aimed at investigating CHIKV infection in Sistan and Baluchistan Province. METHODS: Between April 2017 and June 2018, a total of 159 serum samples of CHIK suspected cases from 10 cities of Sistan and Baluchistan Province were tested by molecular and serological assays. Samples obtained up to 4 days after onset of illness were tested by real time PCR (n = 8). Samples collected 5-10 days after disease onset were subjected to ELISA, as well as real time PCR tests (n = 72). Samples obtained after the 10th day of disease onset were tested by only ELISA (n = 79). Phylogenetic analysis of real time PCR positive samples was carried out by sequencing of a 1014-bp region of Envelope 1 gene (E1 gene). Chi-square and independent t tests were used to evaluate the association between variables and CHIKV infection. RESULTS: In total, 40 (25.1%) out of 159 samples tested positive either by real time PCR or ELISA tests.Out of 151 samples serologically analyzed, 19 (12.6%) and 28 (18.6%) cases were positive for anti-CHIKV IgM and anti-CHIKV IgG antibodies, respectively. Of 80 samples tested by real time PCR, CHIKV RNA was detected in 11 (13.7%) sera, all of them had recent travel history to Pakistan. Additionally, phylogenetic analysis of 5 samples indicated their similarity with recent isolates of Pakistan outbreak 2016-2017 belonging to Indian Ocean sub-lineage of ECSA genotype. A significant correlation between abroad travel history and CHIKV infection was observed (P < 0.001). The most common clinical symptoms included fever, arthralgia/arthritis, myalgia, headache, and chill. CONCLUSIONS: These results present substantial evidence of CHIKV introduction to Iran from Pakistan and emphasize the need for the enhancement of surveillance system and preventive measures.
Subject(s)
Chikungunya Fever/epidemiology , Chikungunya virus/genetics , Chikungunya virus/immunology , Communicable Diseases, Imported/virology , Disease Outbreaks , Adolescent , Adult , Animals , Antibodies, Viral/blood , Arthralgia/epidemiology , Chikungunya virus/isolation & purification , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Fever/epidemiology , Genotype , Humans , Iran/epidemiology , Male , Middle Aged , Mosquito Vectors/virology , Pakistan/epidemiology , Phylogeny , Real-Time Polymerase Chain Reaction , Retrospective Studies , Travel , Viral Envelope Proteins/genetics , Young AdultABSTRACT
Zika virus is a mosquito-borne flavivirus with significant public health concern due to its association with neurological symptoms and intrauterine malformations. Although it is endemic in tropical and subtropical areas, sexual transmission raises the possibility of autochthonous spreading elsewhere. We describe the first laboratory diagnosed imported Zika-infections of Hungary, to highlight the challenges of microbiological identification of the pathogen, caused by serological cross-reactivity and short viremia. Serological examination was carried out using indirect immunofluorescent assay and enzyme-linked immunosorbent assay. Plaque-reduction neutralization test was used for verification purposes. A wide range of clinical specimens: serum, whole-blood, urine, saliva, and semen were analyzed by molecular methods, and sequencing was applied in case of PCR positive results to identify the virus strain. Zika-infected patients with previous vaccination against flaviviruses or possible flavivirus infection in the past showed high serological cross-reactivity, and even cross-neutralizing antibodies were observed. Zika virus RNA could be detected in urine specimen in case of two patients, and in EDTA-anticoagulated whole-blood sample of one patient. The detected strains belong to the Asian lineage of the virus. We presume that serological investigation of imported Zika virus could be altered by infections, vaccination of endemic flaviviruses in Hungary and vice versa.
Subject(s)
Antibodies, Viral/blood , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , Zika Virus Infection/diagnosis , Zika Virus Infection/epidemiology , Adult , Aged , Animals , Clinical Laboratory Techniques , Cross Reactions , Culicidae/virology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Hungary/epidemiology , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Neutralization Tests , Zika Virus Infection/immunologyABSTRACT
Two travellers returning from South America were diagnosed with Andes hantavirus infection, the only member of the Hantaviridae family known to be transmitted from person to person. We describe the clinical course and therapeutic and infection control measures. While both patients showed high viral load (VL) and shedding over several months, 1 patient recovered within 1 week from severe respiratory illness that required noninvasive ventilation, whereas the second patient developed severe hantavirus cardiopulmonary syndrome that required extracorporeal membrane oxygenation for 27 days. The clinical course in the latter patient was complicated by severe disseminated intravascular coagulopathy with diffuse hemorrhage that necessitated mass transfusions, as well as by multiple organ failure, including the need for renal replacement therapy. Results of VL in blood, respiratory secretions, and semen for the first 9 months of follow-up are reported. To our knowledge, these are the first cases of Andes hantavirus infection detected in Europe.
Subject(s)
Communicable Diseases, Imported/virology , Hantavirus Pulmonary Syndrome/diagnosis , Travel-Related Illness , Antibodies, Viral/blood , Disseminated Intravascular Coagulation/virology , Female , Humans , Male , Middle Aged , South America , Switzerland , Thorax/diagnostic imaging , Thorax/virology , Tomography, X-Ray Computed , Viral LoadABSTRACT
Seoul hantavirus-associated hemorrhagic fever with renal syndrome cases are rare outside Asia and have not yet been found in Germany. We report clinical and molecular evidence for a Seoul virus infection in a patient in Germany. The infection was most likely acquired during a stay in Sulawesi, Indonesia.
Subject(s)
Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , Hemorrhagic Fever with Renal Syndrome/epidemiology , Hemorrhagic Fever with Renal Syndrome/virology , Seoul virus , Travel-Related Illness , Aged , Biomarkers , Communicable Diseases, Imported/diagnosis , Communicable Diseases, Imported/transmission , Germany/epidemiology , Hemorrhagic Fever with Renal Syndrome/diagnosis , Hemorrhagic Fever with Renal Syndrome/transmission , Hospitalization , Humans , Indonesia/epidemiology , Male , Phylogeny , RNA, Viral , Seoul virus/classification , Seoul virus/genetics , Sequence Analysis, DNAABSTRACT
Nosocomial transmission of Lassa virus (LASV) is reported to be low when care for the index patient includes proper barrier nursing methods. We investigated whether asymptomatic LASV infection occurred in healthcare workers who used standard barrier nursing methods during the first 15 days of caring for a patient with Lassa fever in Sweden. Of 76 persons who were defined as having been potentially exposed to LASV, 53 provided blood samples for detection of LASV IgG. These persons also responded to a detailed questionnaire to evaluate exposure to different body fluids from the index patient. LASV-specific IgG was not detected in any of the 53 persons. Five of 53 persons had not been using proper barrier nursing methods. Our results strengthen the argument for a low risk of secondary transmission of LASV in humans when standard barrier nursing methods are used and the patient has only mild symptoms.
Subject(s)
Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/virology , Cross Infection/epidemiology , Cross Infection/virology , Lassa Fever/epidemiology , Lassa Fever/virology , Nursing Care , Adult , Aged , Communicable Diseases, Imported/transmission , Cross Infection/transmission , Female , Health Personnel , Humans , Lassa Fever/transmission , Lassa virus/classification , Lassa virus/genetics , Lassa virus/immunology , Male , Middle Aged , Nursing Care/methods , Sentinel Surveillance , Sweden/epidemiologyABSTRACT
BACKGROUND: Dengue is the most common mosquito-borne infection worldwide and a serious threat to global public health. Sporadic dengue virus serotype 2 (DENV-2) imported cases from Myanmar have been documented almost every year in Yunnan Province of China since 2005. However, the complete genome sequences of DENV-2 isolates imported from Myanmar are not available. METHODS: The full-length genome of the DENV-2 strain (YNPE2), isolated from an imported case from Myanmar in 2013, was identified by the next-generation sequencing. The extreme ends of the viral genome were validated by 5'/3' RACE and Sanger sequencing. Furthermore, phylogenetic, recombination and selection pressure analyses were conducted for the molecular characterization of YNPE2 strain. RESULTS: Whole-genome sequencing revealed that the full-length sequence of YNPE2 strain was 10,724 bases, with an open reading frame encoding for 3391 amino acids. The YNPE2 strain had 99.0% nucleotide identity and 99.8% amino acid identity with two closely related strains, ThD2_0078_01 strain (DQ181797) and DENV-2/TH/BID-V2157/200 strain (FJ639832). The phylogenetic analysis suggested that the YNPE2 strain belonged to Asian I genotype and was likely derived from Thailand strain (DQ181797). Moreover, selection pressure analysis revealed two amino acid sites of the NS4B and NS5 proteins, with important evidence of positive selection. CONCLUSION: This study revealed the first complete genome sequence and molecular characterization of a DENV-2 strain (YNPE2) isolated from an imported case from Myanmar, thus providing a valuable reference genome source for future surveillance, epidemiology and vaccine development of DENV-2 virus in Yunnan, China.
Subject(s)
Communicable Diseases, Imported/virology , Dengue Virus/genetics , Dengue/virology , Genome, Viral , Serogroup , Adult , Dengue Virus/isolation & purification , Female , Genotype , Humans , Myanmar , Open Reading Frames , Phylogeny , RNA, Viral/genetics , Sequence Analysis, DNA , Sequence HomologyABSTRACT
The dengue virus (DENV), of the genus Flavivirus (Flaviviridae), has four antigenically distinct serotypes, of which DENV-3 is classified into five genotypes. Here, we describe the detection of DENV-3 genotype I in sera of a Brazilian patient travelling from Singapore to Rio de Janeiro, Brazil, by using multiplex real-time RT-PCR, DNA sequencing of the whole envelope protein gene, and phylogenetic analysis. The virus shares ancestry with those identified in Bali, Indonesia, in 2015. It is possible that arboviruses such as Chikungunya ECSA genotype, DENV-4 genotype I, and Zika were introduced in Brazil from other continents during the multiple international events hosted by the country over the last four years, including World Youth Day, the Soccer World Cup, and the Summer Olympics.